All aspects of life science operations, including the testing and evaluating of new treatments, medications, and devices, have remarkable potential for advancement with artificial intelligence.
For many years, the clinical trial procedure remained largely unaltered. It’s a tried-and-true method of ensuring the safety and efficacy of the medications that reach the market. Clinical trials have a very high attrition rate, although they are generally very effective.
In this area, AI has already made significant progress. Applications like machine learning, deep learning, and natural language processing promise to speed up, streamline, and reduce the cost of clinical trials while putting patient involvement at the center of the procedure.
Additionally, AI has the potential to significantly raise the likelihood of approval and ultimately enhance patient outcomes. Here’s a look at how artificial intelligence is advancing the field of clinical trials and CROs.
Clinical research is about to undergo multiple revolutions thanks to artificial intelligence (AI).
Clinical trial protocols serve as a manual for investigators and monitors to follow when conducting clinical trials. These protocols cover crucial topics like patient safety, informed consent from study subjects, confidentiality agreements, what to do if a problem arises during the study (serious adverse events), etc.
Procedures for any additional or unforeseen events that might happen during a clinical trial should be included in the protocol.
The poor study design hurts clinical trials’ cost, effectiveness, and the chance of success. To ensure that the most proper protocols are defined using enormous healthcare data sets, you can use AI technologies, particularly natural language processing, to decide and select the best primary and secondary endpoints in study design.
These advantages raise the likelihood of success and assist researchers in creating more precise and realistic plans.
A clinical trial’s site selection and patient recruitment can benefit greatly from AI. Companies will be able to recruit patients more easily for clinical trials by using a variety of applications.
AI can help a business in many ways, saving time and money. For instance, artificial intelligence (AI) can help organizations find potential study sites that can carry out the planned activities with minimal site modifications or rework due to location, equipment accessibility, and time restraints.
By quickly identifying patients who fit into particular groups before conducting eligibility screenings with them, companies can quickly start their clinical trials by using artificial intelligence tools. As a result, researchers will be able to devote more resources to finding participants rather than eliminating candidates.
Monitoring the Study and Live Trial By gathering and analyzing data in real-time, artificial intelligence can assist a business in monitoring a clinical trial. These AI solutions can collect data from various sources, allowing physicians or researchers to understand better how patients respond to a drug trial.
Clinical research provides a wealth of operational data, but numerous applications and functional data silos prevent pharma executives from getting a complete picture of their clinical trials portfolio.
As a result, daily hours are wasted trying to gather and analyze various data sets to optimize trial operations and increase cost and resource efficacy. Pharmaceutical companies can more accurately assess whether a data aberration is an actual risk, enabling more productive and successful visits by combining operational data from clinical trials with AI and advanced predictive capabilities on an analytics platform.
It is notoriously difficult and subjective to make predictions about artificial intelligence, machine learning, and other life science applications. While some commentators are confident in their predictions, others are more cautious.
Some expect AI and machine learning to fundamentally transform every aspect of the pharmaceutical industry, medicine, and healthcare. It’s impossible to predict with certainty whether AI and machine learning will result in a revolution or merely an evolution of the clinical trial process.
In either case, AI applications play a more significant role in how life science businesses run. Life science teams can gain valuable insights from HCP meetings using AI-enabled insights management platforms, such as key concepts, sentiments, and trends.
These insights could result in new market opportunities and better business decisions. Now is the time to embrace AI.
Technology is changing how clinical trials are conducted by making them more accessible to underserved participants, streamlining data collection and analysis, and more. Clinical trial technology eventually has the potential to lessen the demands placed on clinical research while simultaneously improving the patient experience for those who volunteer to participate.